Stay updated on Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    An update to the page’s displayed release/version identifier (from v3.5.2 to v3.5.3), indicating a site revision rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-24T06:11:31.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:37.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated the site revision label from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:17:37.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:19:19.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior government funding notice (Revision: v3.4.1) was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:56:34.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A global notice about a lapse in government funding and NIH operations was added. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:54:56.000Z thumbnail image

Stay in the know with updates to Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.